# A Study Comparing Immunotherapy Alone Versus Immunotherapy Combined With Radiotherapy in Patients With Hepatocellular Carcinoma (HCC) With Vascular Invasion

> **NCT06828380** · PHASE2 · RECRUITING · sponsor: **National Cancer Center, Korea** · enrollment: 128 (estimated)

## Conditions studied

- Advanced Hepatocellular Carcinoma (HCC)

## Interventions

- **RADIATION:** Particle beam radiation therapy

## Key facts

- **NCT ID:** NCT06828380
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-15
- **Primary completion:** 2028-08-06
- **Final completion:** 2028-08-06
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06828380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06828380, "A Study Comparing Immunotherapy Alone Versus Immunotherapy Combined With Radiotherapy in Patients With Hepatocellular Carcinoma (HCC) With Vascular Invasion". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06828380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
